-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We maintain our 12-month target price of $315, valuing TRV shares at 11.4x our 2026 operating EPS estimate of $27.74 (raised by $2.09 on April 17) and at 11.2x our 2027 EPS estimate of $28.05 (raised by $0.40). Our target multiples assume TRV shares trade in line with the three-year average forward multiple of 11x and compare to the peer average of 12x. At current levels, we view the shares as fairly valued, versus peer and historical averages. We applaud TRV's risk management skills, and note the turnaround in Q1 underwriting profitability (a $1.17B profits versus a $305M year-ago loss) amid a 66% drop in catastrophes and improved favorable prior-year loss development trends. However, TRV's top-line growth has stalled amid a more competitive pricing environment, and Q1 operating revenues were flat, Y/Y, and net written premiums fell by 2%, Y/Y. We think the top-line erosion removes a catalyst from the shares.